Medicare Enrolled
Dr. Abhin Singla, M.D.
Addiction Medicine (Internal Medicine) Physician · Joliet, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singla
Dr. Abhin Singla is an addiction medicine physician in Joliet, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Singla performed 6,116 Medicare services across 1,651 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singla received a total of $111,989 from 102 pharmaceutical and/or device companies across 2015 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (internal medicine) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in IL
$111,989 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,116
Medicare services
Top 14% in IL for addiction medicine (internal medicine) physician
1,651
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~306 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
872 | $50 | $91 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
811 | $38 | $82 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
732 | $40 | $103 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
728 | $32 | $85 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
686 | $65 | $186 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
651 | $41 | $127 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
608 | $80 | $218 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
219 | $58 | $156 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
178 | $142 | $422 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
132 | $66 | $192 |
| Monthly chronic pain management bundle A monthly service for chronic pain management that includes diagnosis, assessment, monitoring, and the development or revision of a person-centered care plan. |
82 | $65 | $152 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
75 | $34 | $85 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
66 | $133 | $276 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
60 | $41 | $122 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
52 | $98 | $290 |
| Psychiatric collaborative care management, additional 30 minutes This code covers each additional 30 minutes of psychiatric collaborative care management provided per calendar month. |
46 | $48 | $110 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
36 | $12 | $109 |
| Psychiatric collaborative care follow-up, first 60 minutes A follow-up psychiatric care management visit for subsequent calendar months. The service covers the first 60 minutes of collaborative care coordination. |
30 | $117 | $260 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
27 | $16 | $40 |
| Initial psychiatric collaborative care management, first 70 minutes This service covers the first 70 minutes of psychiatric collaborative care management during the initial calendar month of treatment. |
14 | $124 | $270 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
11 | $32 | $33 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$111,989
Total received (2018-2024)
Avg $15,998/year across 7 years
Top 7% in IL for addiction medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
102
Companies
2,015
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,748 (81.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,241 (19.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,850
2023
$13,912
2022
$11,775
2021
$27,759
2020
$26,040
2019
$14,194
2018
$3,458
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$11,696
AIMMUNE THERAPEUTICS, INC.
$594
AstraZeneca Pharmaceuticals LP
$254
Lilly USA, LLC
$237
Teva Pharmaceuticals USA, Inc.
$199
Novo Nordisk Inc
$190
GlaxoSmithKline, LLC.
$157
HARMONY BIOSCIENCES LLC
$150
PFIZER INC.
$139
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$112
Alkermes, Inc.
$100
Almatica Pharma LLC
$79
Phathom Pharmaceuticals, Inc.
$77
Orexo US, Inc.
$74
Otsuka America Pharmaceutical, Inc.
$69
Axsome Therapeutics, Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$57
IDORSIA PHARMACEUTICALS US INC
$52
Braeburn Inc.
$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$44
Antares Pharma, Inc.
$42
SCILEX PHARMACEUTICALS INC.
$41
Lundbeck LLC
$41
Vanda Pharmaceuticals Inc.
$38
Currax Pharmaceuticals LLC
$37
E.R. Squibb & Sons, L.L.C.
$35
Dexcom, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$27
SK Life Science, Inc.
$26
Boston Scientific Corporation
$25
Indivior Inc.
$19
Harmony Biosciences Llc
$19
Exact Sciences Corporation
$18
Amgen Inc.
$16
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 84.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$32,498
Allergan, Inc.
$26,346
ABBVIE INC.
$20,303
Allergan Inc.
$11,280
Novo Nordisk Inc
$1,790
AstraZeneca Pharmaceuticals LP
$1,774
Otsuka America Pharmaceutical, Inc.
$1,384
Lilly USA, LLC
$1,202
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,128
PFIZER INC.
$994
Teva Pharmaceuticals USA, Inc.
$979
Boehringer Ingelheim Pharmaceuticals, Inc.
$779
Nestle HealthCare Nutrition Inc.
$660
Takeda Pharmaceuticals U.S.A., Inc.
$632
AIMMUNE THERAPEUTICS, INC.
$594
GlaxoSmithKline, LLC.
$585
NESTLE HEALTHCARE NUTRITION INC.
$548
Amgen Inc.
$475
Orexo US, Inc.
$447
Collegium Pharmaceutical, Inc.
$326
Janssen Pharmaceuticals, Inc
$317
Lundbeck LLC
$294
Biohaven Pharmaceutical Holding Company Ltd.
$240
Kowa Pharmaceuticals America, Inc.
$235
Currax Pharmaceuticals LLC
$204
Alkermes, Inc.
$202
E.R. Squibb & Sons, L.L.C.
$199
Almatica Pharma LLC
$190
UPSHER-SMITH LABORATORIES LLC
$190
JAZZ PHARMACEUTICALS INC.
$182
Amarin Pharma Inc.
$180
Merck Sharp & Dohme Corporation
$172
US WorldMeds, LLC
$159
Antares Pharma, Inc.
$156
Indivior Inc.
$153
HARMONY BIOSCIENCES LLC
$150
SANOFI-AVENTIS U.S. LLC
$148
Upsher-Smith Laboratories LLC
$145
Corcept Therapeutics
$144
Shire North American Group Inc
$139
SK Life Science, Inc.
$137
AbbVie, Inc.
$128
USWM, LLC
$123
Bausch Health US, LLC
$112
Amneal Pharmaceuticals LLC
$108
Axsome Therapeutics, Inc.
$107
VIVUS, Inc.
$106
Novartis Pharmaceuticals Corporation
$102
IBSA Pharma Inc.
$101
BioDelivery Sciences International, Inc.
$100
Braeburn Inc.
$96
RedHill Biopharma Inc.
$94
Promius Pharma LLC
$86
Astellas Pharma US Inc
$84
Jazz Pharmaceuticals Inc.
$82
SI-BONE, Inc.
$80
Phathom Pharmaceuticals, Inc.
$77
ARBOR PHARMACEUTICALS, INC.
$74
Horizon Therapeutics plc
$73
Bayer HealthCare Pharmaceuticals Inc.
$70
Bayer Healthcare Pharmaceuticals Inc.
$70
IDORSIA PHARMACEUTICALS US INC
$68
Merck Sharp & Dohme LLC
$68
Daiichi Sankyo Inc.
$60
SCILEX PHARMACEUTICALS INC.
$59
Xeris Pharmaceuticals, Inc.
$59
Sunovion Pharmaceuticals Inc.
$58
Neuronetics, Inc.
$56
Ethicon US, LLC
$53
Hikma Pharmaceuticals USA
$49
Exact Sciences Corporation
$45
Pernix Therapeutics Holdings, Inc.
$45
IMPEL PHARMACEUTICALS INC.
$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$44
Biohaven Pharmaceuticals, Inc.
$43
EISAI INC.
$41
Supernus Pharmaceuticals, Inc.
$40
Vanda Pharmaceuticals Inc.
$38
Egalet US Inc
$38
Clarus Therapeutics Inc.
$36
Kaleo, Inc.
$34
Adlon Therapeutics L.P.
$32
Scilex Pharmaceuticals Inc.
$32
Dexcom, Inc.
$30
Synergy Pharmaceuticals Inc
$30
Philips Electronics North America Corporation
$30
Avanir Pharmaceuticals, Inc.
$28
Arbor Pharmaceuticals, Inc.
$28
Purdue Pharma L.P.
$26
Boston Scientific Corporation
$25
Eisai Inc.
$23
ITI, Inc.
$23
Abbott Laboratories
$23
Esperion Therapeutics, Inc.
$20
Harmony Biosciences Llc
$19
VIVUS LLC
$18
Harmony Biosciences LLC
$17
Azurity Pharmaceuticals, Inc.
$17
Medtronic MiniMed, Inc.
$16
Shionogi Inc
$14
ASSERTIO THERAPEUTICS, Inc.
$12
Aytu BioScience, Inc
$11
Top 3 companies account for 70.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ABILIFY MAINTENA · ADHANSIA XR · ADVAIR · AIRSUPRA · AJOVY · ALSUMA · ANORO · ANORO ELLIPTA · APLENZIN · ARISTADA · AUSTEDO · Aimovig · Amitiza · Austedo XR · Auvelity · BASAGLAR · BELBUCA · BELSOMRA · BOTOX · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BRINTELLIX · BRIXADI · BUNAVAIL 2.1 mg 30-count box · BYDUREON · BYSTOLIC · Belviq · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · CREON · Cambia · Cologuard Collection Kit · Creon · DUEXIS · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVZIO · Evzio · FANAPT · FARXIGA · FLECTOR · FREESTYLE LIBRE 3 · GRALISE · GVOKE PFS · Horizant · INVOKAMET · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kloxxado · Korlym · LATUDA · LINX Reflux Management System · LINZESS · LIVALO · LOREEV XR · LYBALVI · LYRICA · Licart · Livalo · Lucemyra · Lucemyra/Lofexidine · MIGRANAL · MOTEGRITY · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · Mitigare · Morphabond ER · Motegrity · Movantik · NAPRELAN · NEUROSTAR TMS THERAPY · NEXLIZET · NOCDURNA · NUEDEXTA · NURTEC ODT · Natesto · Nucynta · ONZETRA XSAIL · Otezla · Otrexup · Ozempic · PANCREAZE · Pancreaze · QSYMIA · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RELISTOR ORAL · REXULTI · REYVOW · RYBELSUS · RYTARY · Rybelsus · SEGLENTIS · SHINGRIX · SILENOR · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRIX · STIOLTO RESPIMAT · SUBLOCADE · SUNOSI · SYMBICORT · SYMJEPI · SYMPROIC · SYNJARDY · SYNTHROID · Saxenda · Sunosi · Symproic · TLANDO · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Trintellix · Trudhesa · Trulance · UBRELVY · UNITHROID · Utibron · VESICARE · VIBERZI · VIVITROL · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Victoza · Vivitrol 380 mg · Vyvanse · WAKIX · WATCHMAN FLX · WELLBUTRIN · Wegovy · XARELTO · XCOPRI · XIFAXAN · XTAMPZA · XTAMPZAER · XYOSTED · Xyrem · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZENPEP · ZOHYDRO ER · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zubsolv · iFuse Implant · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in addiction medicine (internal medicine) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for addiction medicine (internal medicine) physician in IL.
Geographic Context
Addiction medicine physicians within 10 mi
3
Per 100K population
0.4
County median income
$107,799
Nearest hospital
SAINT JOSEPH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Singla is a clinical cardiology specialist, with above-average Medicare volume (top 14% in IL), with speaking/promotional industry engagement in the top 7% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Singla experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Singla performed 872 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singla receive payments from pharmaceutical companies?
Yes. Dr. Singla received a total of $111,989 from 102 companies across 2,015 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singla's costs compare to other addiction medicine physicians in Joliet?
Dr. Singla's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Addiction Medicine Physicians in Joliet
Browse addiction medicine physicians in Joliet ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in IL
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in IL
Which IL addiction medicine physicians receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology